Dr. Burak Altintas, MD

Dr. Altintas practices at John Sealy Hospital in Galveston, Texas, part of The University of Texas System.

Dr. Altintas' NPI, 1831604552, was assigned on December 4, 2017. Dr. Altintas graduated from University of Heidelberg Faculty of Medicine in 2009. Dr. Altintas holds Arizona license 67463.

Dr. Altintas' primary practice is John Sealy Hospital, at 301 University Boulevard, Galveston, TX 77555 in Galveston County. The practice phone is (409) 772-1011.

Dr. Altintas' primary practice is John Sealy Hospital in Galveston, Texas, part of The University of Texas System. Dr. Altintas is also affiliated with Houston Methodist Clear Lake Hospital. The medical group on file is UTMB Faculty Group Practice. Dmand AI also links Dr. Altintas to 1 more hospital, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Altintas practices, 4 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Altintas' primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dmand AI has Dr. Altintas' licenses on file in 5 states: Arizona, New York, Virginia, Colorado and Kentucky.

Dmand AI lists amputation, arm, wrist, hand fracture and dislocation, arthritis, back and neck pain treatment without fusion, bursitis, enthesopathy in arms, hip replacement and joint pain among the conditions Dr. Altintas treats.

CMS data shows 196 Medicare services from Dr. Altintas across 5 procedure codes in 2024, for 120 Medicare patients. Medicare paid $10,745 for them. Every service was in an office.

CMS counts 120 Medicare patients who saw Dr. Altintas in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Altintas' median patient age at 71, with 66% women.

In 2024, Dr. Altintas wrote 12 Medicare Part D claims for 11 patients. 100% of them were for generic drugs. They cover 2 drugs, with $897 in total drug cost. In 2022, CMS named 40 claims across 1 drug.

Dr. Altintas accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 33 papers to Dr. Altintas, published from 2008 to 2025. 2019 was the busiest year, with 6. The most frequent topics are Arthroscopy, Rotator Cuff Injuries and Shoulder Joint. Dr. Altintas has published most often in Arthroscopy. Dr. Altintas' most frequent co-authors are Peter James Millett, MD, Robert Ernest Boykin, MD and David L. Helfet, MD.

CMS Open Payments shows 106 general payments to Dr. Altintas from 16 drug and device companies from 2018 to 2025. Grants make up the largest share, 42% of the total. Arthrex, Inc. paid the most, $23,350.

Dr. Altintas graduated from University of Heidelberg Faculty of Medicine in 2009.

Dr. Altintas is in network with 23 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.